Trends in Cardiovascular Medicine
Volume 15, Issue 8 , Pages 302-308 , November 2005

Regulation of Weibel–Palade Body Exocytosis

References 

  1. Bhatia R, Matsushita K, Yamakuchi M, et al. Ceramide triggers Weibel–Palade body exocytosis. Circ Res. 2004;95:319–324
  2. Block MR, Glick BS, Wilcox CA, et al. Purification of an N-ethylmaleimide-sensitive protein catalyzing vesicular transport. Proc Natl Acad Sci U S A. 1988;85:7852–7856
  3. Bonfanti R, Furie BC, Furie B, et al. PADGEM (GMP140) is a component of Weibel–Palade bodies of human endothelial cells. Blood. 1989;73:1109–1112
  4. Cai H, Griendling KK, Harrison DG. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol Sci. 2003;24:471–478
  5. Cambien B, Wagner DD. A new role in hemostasis for the adhesion receptor P-selectin. Trends Mol Med. 2004;10:179–186
  6. Datta YH, Ewenstein BM. Regulated secretion in endothelial cells: biology and clinical implications. Thromb Haemost. 2001;86:1148–1155
  7. Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation. 2004;109:III27–III32
  8. De Groot PG, Gonsalves MD, Loesberg C, et al. Thrombin-induced release of von Willebrand factor from endothelial cells is mediated by phospholipid methylation. Prostacyclin synthesis is independent of phospholipid methylation. J Biol Chem. 1984;259:13329–13333
  9. De Leeuw HP, Wijers-Koster PM, Van Mourik JA, et al. Small GTP-binding protein RalA associates with Weibel–Palade bodies in endothelial cells. Thromb Haemost. 1999;82:1177–1181
  10. De Leeuw HP, Fernandez-Borja M, Reits EA, et al. Small GTP-binding protein Ral modulates regulated exocytosis of von Willebrand factor by endothelial cells. Arterioscler Thromb Vasc Biol. 2001;21:899–904
  11. Denis C, Methia N, Frenette PS, et al. A mouse model of severe von Willebrand disease: defects in hemostasis and thrombosis. Proc Natl Acad Sci U S A. 1998;95:9524–9529
  12. Ewenstein BM, Warhol MJ, Handin RI, et al. Composition of the von Willebrand factor storage organelle (Weibel–Palade body) isolated from cultured human umbilical vein endothelial cells. J Cell Biol. 1987;104:1423–1433
  13. Fayos BE, Wattenberg BW. Regulated exocytosis in vascular endothelial cells can be triggered by intracellular guanine nucleotides and requires a hydrophobic, thiol-sensitive component. Studies of regulated von Willebrand factor secretion from digitonin permeabilized endothelial cells. Endothelium. 1997;5:339–350
  14. Foreman KE, Vaporciyan AA, Bonish BK, et al. C5a-induced expression of P-selectin in endothelial cells. J Clin Invest. 1994;94:1147–1155
  15. Frenette PS, Denis CV, Weiss L, et al. P-Selectin glycoprotein ligand 1 (PSGL-1) is expressed on platelets and can mediate platelet–endothelial interactions in vivo. J Exp Med. 2000;191:1413–1422
  16. Fu J, Naren AP, Gao X, et al. Protease-activated receptor-1 activation of endothelial cells induces protein kinase Calpha-dependent phosphorylation of syntaxin 4 and Munc18c: role in signaling P-selectin expression. J Biol Chem. 2005;280:3178–3184
  17. Galbusera M, Zoja C, Donadelli R, et al. Fluid shear stress modulates von Willebrand factor release from human vascular endothelium. Blood. 1997;90:1558–1564
  18. Hallahan DE, Virudachalam S. Ionizing radiation mediates expression of cell adhesion molecules in distinct histological patterns within the lung. Cancer Res. 1997;57:2096–2099
  19. Hallahan DE, Virudachalam S. Accumulation of P-selectin in the lumen of irradiated blood vessels. Radiat Res. 1999;152:6–13
  20. Hallahan DE, Staba-Hogan MJ, Virudachalam S, et al. X-Ray-induced P-selectin localization to the lumen of tumor blood vessels. Cancer Res. 1998;58:5216–5220
  21. Hannah MJ, Hume AN, Arribas M, et al. Weibel–Palade bodies recruit Rab27 by a content-driven, maturation-dependent mechanism that is independent of cell type. J Cell Sci. 2003;116:3939–3948
  22. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685–1695
  23. Hattori R, Hamilton KK, McEver RP, et al. Complement proteins C5b–9 induce secretion of high molecular weight multimers of endothelial von Willebrand factor and translocation of granule membrane protein GMP-140 to the cell surface. J Biol Chem. 1989;264:9053–9060
  24. Hess DT, Matsumoto A, Kim SO, et al. Protein S-nitrosylation: purview and parameters. Nat Rev Mol Cell Biol. 2005;6:150–166
  25. Huang Y, Man HY, Sekine-Aizawa Y, et al. S-Nitrosylation of N-ethylmaleimide sensitive factor mediates surface expression of AMPA receptors. Neuron. 2005;46:533–540
  26. Jahn R. Principles of exocytosis and membrane fusion. Ann N Y Acad Sci. 2004;1014:170–178
  27. Jahn R, Sudhof TC. Membrane fusion and exocytosis. Annu Rev Biochem. 1999;68:863–911
  28. Jahn R, Lang T, Sudhof TC. Membrane fusion. Cell. 2003;112:519–533
  29. Kagawa H, Fujimoto S. Electron-microscopic and immunocytochemical analyses of Weibel–Palade bodies in the human umbilical vein during pregnancy. Cell Tissue Res. 1987;249:557–563
  30. Kuhlencordt PJ, Chen J, Han F, et al. Genetic deficiency of inducible nitric oxide synthase reduces atherosclerosis and lowers plasma lipid peroxides in apolipoprotein E-knockout mice. Circulation. 2001;103:3099–3104
  31. Kuhlencordt PJ, Gyurko R, Han F, et al. Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice. Circulation. 2001;104:448–454
  32. Levy GG, Motto DG, Ginsburg D. ADAMTS13 turns 3. Blood. 2005;106:11–17
  33. Loesberg C, Gonsalves MD, Zandbergen J, et al. The effect of calcium on the secretion of factor VIII-related antigen by cultured human endothelial cells. Biochim Biophys Acta. 1983;763:160–168
  34. Lonn E, Bosch J, Yusuf S, et al. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA. 2005;293:1338–1347
  35. Malhotra V, Orci L, Glick BS, et al. Role of an N-ethylmaleimide-sensitive transport component in promoting fusion of transport vesicles with cisternae of the Golgi stack. Cell. 1988;54:221–227
  36. Matsushita K, Morrell CN, Cambien B, et al. Nitric oxide regulates exocytosis by S-nitrosylation of N-ethylmaleimide-sensitive factor. Cell. 2003;115:139–150
  37. Matsushita K, Morrell CN, Lowenstein CJ. Sphingosine 1-phosphate activates Weibel–Palade body exocytosis. Proc Natl Acad Sci U S A. 2004;101:11483–11487
  38. Matsushita K, Morrell CN, Lowenstein CJ. A novel class of fusion polypeptides inhibits exocytosis. Mol Pharmacol. 2005;67:1137–1144
  39. Matsushita K, Morrell CN, Mason RJ, et al. Hydrogen peroxide regulation of endothelial exocytosis by inhibition of N-ethylmaleimide sensitive factor. J Cell Biol. 2005;170:73–79
  40. Matsushita K, Yamakuchi M, Morrell CN, et al. Vascular endothelial growth factor regulation of Weibel–Palade-body exocytosis. Blood. 2005;105:207–214
  41. Mayadas TN, Johnson RC, Rayburn H, et al. Leukocyte rolling and extravasation are severely compromised in P selectin-deficient mice. Cell. 1993;74:541–554
  42. McEver RP, Beckstead JH, Moore KL, et al. GMP-140, a platelet alpha-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel–Palade bodies. J Clin Invest. 1989;84:92–99
  43. Mellman I, Warren G. The road taken: past and future foundations of membrane traffic. Cell. 2000;100:99–112
  44. Morrell CN, Matsushita K, Chiles K, et al. Regulation of platelet granule exocytosis by S-nitrosylation. Proc Natl Acad Sci U S A. 2005;102:3782–3787
  45. Morrell CN, Matsushita K, Lowenstein CJ. A novel inhibitor of N-ethylmaleimide-sensitive factor decreases leukocyte trafficking and peritonitis. J Pharmacol Exp Ther. 2005;314:155–161
  46. Ota H, Fox-Talbot K, Hu W, et al. Terminal complement components mediate release of von Willebrand factor and adhesion of platelets in arteries of allografts. Transplantation. 2005;79:276–281
  47. Palmer DS, Aye MT, Ganz PR, et al. Adenosine nucleotides and serotonin stimulate von Willebrand factor release from cultured human endothelial cells. Thromb Haemost. 1994;72:132–139
  48. Pinsky DJ, Naka Y, Liao H, et al. Hypoxia-induced exocytosis of endothelial cell Weibel–Palade bodies. A mechanism for rapid neutrophil recruitment after cardiac preservation. J Clin Invest. 1996;97:493–500
  49. Pober JS, Cotran RS. The role of endothelial cells in inflammation. Transplantation. 1990;50:537–544
  50. Qian Z, Gelzer-Bell R, Yang S-x, et al. Inducible nitric oxide synthase inhibition of Weibel–Palade body release in cardiac transplant rejection. Circulation. 2001;104:2369–2375
  51. Reidy MA, Chopek M, Chao S, et al. Injury induces increase of von Willebrand factor in rat endothelial cells. Am J Pathol. 1989;134:857–864
  52. Ribes JA, Francis CW, Wagner DD. Fibrin induces release of von Willebrand factor from endothelial cells. J Clin Invest. 1987;79:117–123
  53. Romo GM, Dong JF, Schade AJ, et al. The glycoprotein Ib-IX-V complex is a platelet counterreceptor for P-selectin. J Exp Med. 1999;190:803–814
  54. Rondaij MG, Sellink E, Gijzen KA, et al. Small GTP-binding protein Ral is involved in cAMP-mediated release of von Willebrand factor from endothelial cells. Arterioscler Thromb Vasc Biol. 2004;24:1315–1320
  55. Rudic RD, Shesely EG, Maeda N, et al. Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling. J Clin Invest. 1998;101:731–736
  56. Ruggeri ZM. Platelets in atherothrombosis. Nat Med. 2002;8:1227–1234
  57. Ruggeri ZM. Von Willebrand factor, platelets and endothelial cell interactions. J Thromb Haemost. 2003;1:1335–1342
  58. Sadler JE. Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem. 1998;67:395–424
  59. Schluter T, Bohnensack R. Serotonin-induced secretion of von Willebrand factor from human umbilical vein endothelial cells via the cyclic AMP-signaling systems independent of increased cytoplasmic calcium concentration. Biochem Pharmacol. 1999;57:1191–1197
  60. Shears LL, Kawaharada N, Tzeng E, et al. Inducible nitric oxide synthase suppresses the development of allograft arteriosclerosis. J Clin Invest. 1997;100:2035–2042
  61. Shreeniwas R, Koga S, Karakurum M, et al. Hypoxia-mediated induction of endothelial cell interleukin-1 alpha. An autocrine mechanism promoting expression of leukocyte adhesion molecules on the vessel surface. J Clin Invest. 1992;90:2333–2339
  62. Sporn LA, Marder VJ, Wagner DD. Inducible secretion of large, biologically potent von Willebrand factor multimers. Cell. 1986;46:185–190
  63. Stamler JS, Simon DI, Osborne JA, et al. S-Nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc Natl Acad Sci U S A. 1992;89:444–448
  64. Stamler JS, Singel DJ, Loscalzo J. Biochemistry of nitric oxide and its redox-activated forms. Science. 1992;258:1898–1902
  65. Subramaniam M, Koedam JA, Wagner DD. Divergent fates of P- and E-selectins after their expression on the plasma membrane. Mol Biol Cell. 1993;4:791–801
  66. Utgaard JO, Jahnsen FL, Bakka A, et al. Rapid secretion of prestored interleukin 8 from Weibel–Palade bodies of microvascular endothelial cells. J Exp Med. 1998;188:1751–1756
  67. Van Mourik JA, Romani de Wit T, Voorberg J. Biogenesis and exocytosis of Weibel–Palade bodies. Histochem Cell Biol. 2002;117:113–122
  68. Vischer UM, Wollheim CB. Purine nucleotides induce regulated secretion of von Willebrand factor: involvement of cytosolic Ca2+ and cyclic adenosine monophosphate-dependent signaling in endothelial exocytosis. Blood. 1998;91:118–127
  69. Vischer UM, Barth H, Wollheim CB. Regulated von Willebrand factor secretion is associated with agonist-specific patterns of cytoskeletal remodeling in cultured endothelial cells. Arterioscler Thromb Vasc Biol. 2000;20:883–891
  70. Vora DK, Fang ZT, Liva SM, et al. Induction of P-selectin by oxidized lipoproteins. Separate effects on synthesis and surface expression. Circ Res. 1997;80:810–818
  71. Wagner DD, Marder VJ. Biosynthesis of von Willebrand protein by human endothelial cells. Identification of a large precursor polypeptide chain. J Biol Chem. 1983;258:2065–2067
  72. Wagner DD, Olmsted JB, Marder VJ. Immunolocalization of von Willebrand protein in Weibel–Palade bodies of human endothelial cells. J Cell Biol. 1982;95:355–360
  73. Wagner DD, Saffaripour S, Bonfanti R, et al. Induction of specific storage organelles by von Willebrand factor propolypeptide. Cell. 1991;64:403–413
  74. Weibel ER, Palade GE. New cytoplasmic components in arterial endothelia. J Cell Biol. 1964;23:101–112
  75. Whiteheart SW, Rossnagel K, Buhrow SA, et al. N-Ethylmaleimide-sensitive fusion protein: a trimeric ATPase whose hydrolysis of ATP is required for membrane fusion. J Cell Biol. 1994;126:945–954
  76. Whiteheart SW, Schraw T, Matveeva EA. N-Ethylmaleimide sensitive factor (NSF) structure and function. Int Rev Cytol. 2001;207:71–112
  77. Wolff B, Burns AR, Middleton J, et al. Endothelial cell “memory” of inflammatory stimulation: human venular endothelial cells store interleukin 8 in Weibel–Palade bodies. J Exp Med. 1998;188:1757–1762
  78. Yamada S, Mayadas TN, Yuan F, et al. Rolling in P-selectin-deficient mice is reduced but not eliminated in the dorsal skin. Blood. 1995;86:3487–3492
  79. Yusuf S, Dagenais G, Pogue J, et al. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342:154–160
  80. Zizzi HC, Zibari GB, Granger DN, et al. Quantification of P-selectin expression after renal ischemia and reperfusion. J Pediatr Surg. 1997;32:1010–1013

PII: S1050-1738(05)00184-2

doi: 10.1016/j.tcm.2005.09.005

Trends in Cardiovascular Medicine
Volume 15, Issue 8 , Pages 302-308 , November 2005

Article Tools

* Image Usage & Resolution